Dermata Payables Turnover from 2010 to 2024

DRMAW Stock  USD 0.01  0.00  0.00%   
Dermata Therapeutics Payables Turnover yearly trend continues to be fairly stable with very little volatility. Payables Turnover is likely to outpace its year average in 2024. Payables Turnover is a liquidity ratio that shows how quickly Dermata Therapeutics Warrant pays off its suppliers by dividing total purchases by average accounts payable. View All Fundamentals
 
Payables Turnover  
First Reported
2010-12-31
Previous Quarter
0.003551
Current Value
0.003908
Quarterly Volatility
0.0003847
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Dermata Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Dermata Therapeutics' main balance sheet or income statement drivers, such as Net Interest Income of 213.6 K, Depreciation And Amortization of 8.4 M or Interest Expense of 111.4 K, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 0.29. Dermata financial statements analysis is a perfect complement when working with Dermata Therapeutics Valuation or Volatility modules.
  
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation.

Latest Dermata Therapeutics' Payables Turnover Growth Pattern

Below is the plot of the Payables Turnover of Dermata Therapeutics Warrant over the last few years. It is a liquidity ratio that shows how quickly a company pays off its suppliers by dividing total purchases by average accounts payable. Dermata Therapeutics' Payables Turnover historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Dermata Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Payables Turnover10 Years Trend
Slightly volatile
   Payables Turnover   
       Timeline  

Dermata Payables Turnover Regression Statistics

Arithmetic Mean0
Geometric Mean0
Coefficient Of Variation10.14
Mean Deviation0.0003
Median0
Standard Deviation0.0004
Sample Variance0.00000015
Range9.0E-4
R-Value(0.61)
Mean Square Error0.0000001
R-Squared0.37
Significance0.02
Slope(0.000053)
Total Sum of Squares0.00000207

Dermata Payables Turnover History

2024 0.003908
2023 0.003551
2020 0.003088

About Dermata Therapeutics Financial Statements

Dermata Therapeutics investors use historical fundamental indicators, such as Dermata Therapeutics' Payables Turnover, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Dermata Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Dermata Stock Analysis

When running Dermata Therapeutics' price analysis, check to measure Dermata Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dermata Therapeutics is operating at the current time. Most of Dermata Therapeutics' value examination focuses on studying past and present price action to predict the probability of Dermata Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dermata Therapeutics' price. Additionally, you may evaluate how the addition of Dermata Therapeutics to your portfolios can decrease your overall portfolio volatility.